Approval · Notice of Compliance 33785 · 2024
LOPERACAP: Notice of Compliance 33785
Issued August 9, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33785
- Date
- August 9, 2024
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update PM and migrate to master template as per Reference PM
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOPERACAP | Not yet assigned | — |
Medicinal ingredients
- LOPERAMIDE HCL 2 MG per TAB